Präventionsmaßnahmen bei rezidivierender bakterieller Zystitis der Frau: Orale Immuntherapie und Low-dose-Antibiotikagabe als Langzeitmaßnahmen

Bauer et al. Orale Immuntherapie als Präventionsmaßnahme bei rezidivierenden Harnwegsinfektionen: Kosten-Nutzen-Analyse (im Druck) Bosch A, Benedi VJ, Parès R, Jofre J (1988) Enhancement of the humoral immune response and resistance to bacterial infection by the oral administration of a bacterial immunomodulator. J Immunopharm Immunotox 10: 333 Bottex C, Boyer G, Fontanges R (1989) Efficacy of an immunomodulator in compensating antibiotic-induced immunosuppression. Int J Immunopath Pharm 2: 41 Brunschweiger S, Eulitz S, Mayer P, Hoffstetter A (1992) Ergebnisse der Prüfung eines oralen Immunstimulans und der Low-dose-Chemoprophylaxe zur Therapie rezidivierender Harnwegsinfektionen der Frau. In: Klinische und experimentelle Urologie. Zuckschwerdt, München, p 36 Frey C, Obolensky W, Wyss H (1986) Treatment of recurrent urinary tract infections: efficacy of an orally administered biological response modifier. Urol Int 41: 444 Hachen HJ (1990) Oral immunotherapy in paraplegic patients with chronic urinary tract infections. J Urol 143: 759 Hoffmann P (1988) Immunobiologische Behandlung von Harnwegsinfektionen. Therapiewoche 6: 475 Kaufmann DB, Katz R, McIntosh RM (1970) Secretory IgA in urinary tract infections. Br Med J 4: 463 Mestecky J, McGhee JR, Arnold RR, Michalek SM, Prince SJ, Babb JL (1978) Selective Induction of an Immune Response in Human External Secretions by Ingestion of Bacterial Antigen. J Clin Invest 61: 731 Mestecky J (1987) The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol 7: 265 Riedl-Seifert J, van Aubel A, Casals J (1990) Orale Immunstimulation — Die Mukosa und ihre immunologischen Möglichkeiten. ZFA 66: 717 Riedl-Seifert RJ, Van Vaubel A (1992) Orale Stimulation des Mukosaimmunsystems. Fortschr Med 108: 47 Rosenthal M (1986) Effect of a bacterial extract on cellular and humoral immune response in humans. J Immunopharmacol 8: 315 Rüttgers H, Grischke E (1987) Elevation of secretory IgA antibodies in the urinary tract by immunostimulation for the pre-operative treatment and postoperative prevention of urinary tract infections. Urol Int 42: 424–426 Rüttgers H, Grischke EM (1987) Urinary tract infections in women. Current unsatisfactory situation and prospects of a new therapeutic concept. Urol Int 42: 342 Rugendorff EW (1992) Immunological therapy of recurrent urinary tract infections with immunoactive E. coli fractions in women. Inter Urogynecol J 3: 179 Rugendorff EW (1993) Klinische Erfahrungen mit Immunstimulation bei rezidivierender Zystitis. Urologe B 33: 326 Schaeffer AJ (1992) Infections of the urinary tract. In: Walsh PC, Stamey TA, Darracott Vaughan E Jr (eds) Campbell’s Urology vol. 1, 6. edn. Saunders, Philadelphia, p 771 Schneider H-J (1990) Immunstimulation — Neuer Therapieansatz bei rezidivierenden Harnwegsinfekten. Allgemeinarzt 12: 626 Schulman CC, Corbusier A, Michiels H, Taenzer HJ (1993) Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo controlled multicentre study. J Urol 150: 917 Tammen H, Frey C (1988) Behandlung rezidivierender Harnwegsinfekte mit Uro-Vaxom. Urologe B 28: 294 Tammen H, The German Urinary Tract Infection Study Group (1990) Immunobiotherapy with Uro-Vaxom in recurrent urinary tract infection. Br J Urol 65: 6 Wybran J, Libin M, Schandene L (1989) Enhancement of cytokine production and natural killer activity by an Escherichia coli extract. Z Onkol 12: 22 Stamey T, et al. (1978) The immunologic basis of recurrent bacteriuria; role of cervicovaginal antibody in enterobacterial colonization of the introital mucosa. Medicine 57: 47 Stamey T, Sexton CC (1975) The role of vaginal colonization with enterobacteriaceae in recurrent urinary tract infections. J Urol 113: 214 Shortliffe LMD (1992) Urinary tract infections in infants and children. Campell’s Urology vol 2, 6. edn. Saunders, Philadelphia, p 1669 Hopkins WJ (1995) Western blot analysis of anti-escherichia coli serum immunoglobulins in women susceptible to recurrent urinary tract infections. JID 172: 1612 Bottex C et al. (1988) Effects of two bacterial extracts, OM-89 and Broncho-Vaxom, on IL-1 release and metabolic activity of a murine macrophage cellline. Int J Immunother 4: 203–212